AAPL   314.93 (-0.57%)
FB   224.65 (-3.25%)
GOOGL   1,407.27 (-0.99%)
AMZN   2,375.81 (-1.90%)
NVDA   330.51 (-5.22%)
CGC   19.37 (-3.20%)
MU   44.45 (-2.95%)
GE   7.32 (+7.65%)
AMD   50.25 (-5.33%)
T   31.89 (+3.47%)
ACB   15.36 (-1.60%)
F   6.01 (+2.91%)
GILD   73.58 (+0.55%)
DIS   120.90 (-0.04%)
BAC   25.47 (+4.90%)
BA   145.83 (+0.75%)
AAPL   314.93 (-0.57%)
FB   224.65 (-3.25%)
GOOGL   1,407.27 (-0.99%)
AMZN   2,375.81 (-1.90%)
NVDA   330.51 (-5.22%)
CGC   19.37 (-3.20%)
MU   44.45 (-2.95%)
GE   7.32 (+7.65%)
AMD   50.25 (-5.33%)
T   31.89 (+3.47%)
ACB   15.36 (-1.60%)
F   6.01 (+2.91%)
GILD   73.58 (+0.55%)
DIS   120.90 (-0.04%)
BAC   25.47 (+4.90%)
BA   145.83 (+0.75%)
AAPL   314.93 (-0.57%)
FB   224.65 (-3.25%)
GOOGL   1,407.27 (-0.99%)
AMZN   2,375.81 (-1.90%)
NVDA   330.51 (-5.22%)
CGC   19.37 (-3.20%)
MU   44.45 (-2.95%)
GE   7.32 (+7.65%)
AMD   50.25 (-5.33%)
T   31.89 (+3.47%)
ACB   15.36 (-1.60%)
F   6.01 (+2.91%)
GILD   73.58 (+0.55%)
DIS   120.90 (-0.04%)
BAC   25.47 (+4.90%)
BA   145.83 (+0.75%)
AAPL   314.93 (-0.57%)
FB   224.65 (-3.25%)
GOOGL   1,407.27 (-0.99%)
AMZN   2,375.81 (-1.90%)
NVDA   330.51 (-5.22%)
CGC   19.37 (-3.20%)
MU   44.45 (-2.95%)
GE   7.32 (+7.65%)
AMD   50.25 (-5.33%)
T   31.89 (+3.47%)
ACB   15.36 (-1.60%)
F   6.01 (+2.91%)
GILD   73.58 (+0.55%)
DIS   120.90 (-0.04%)
BAC   25.47 (+4.90%)
BA   145.83 (+0.75%)
Log in

NASDAQ:XBITXBiotech Insider Trades

$13.94
-0.83 (-5.62 %)
(As of 05/27/2020 12:00 PM ET)
Add
Compare
Today's Range
$13.88
Now: $13.94
$14.93
50-Day Range
$11.49
MA: $14.21
$16.07
52-Week Range
$6.76
Now: $13.94
$26.40
Volume12,001 shs
Average Volume238,846 shs
Market Capitalization$402.17 million
P/E RatioN/A
Dividend YieldN/A
Beta1.51

Insider Trades

XBiotech (NASDAQ:XBIT) Insider Buying and Selling Activity

Insider Ownership Percentage: 30.98%

Insider Buying and Selling by Quarter


XBiotech (NASDAQ XBIT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/19/2020Street Financial S.A. BayMajor ShareholderSell1,662,616$6.38$10,607,490.083,337,384  
6/4/2019Fondation RennesMajor ShareholderBuy1,200,000$8.25$9,900,000.005,110,282  
3/4/2019Fondation RennesMajor ShareholderBuy16,426$7.91$129,929.66  
3/1/2019Fondation RennesMajor ShareholderBuy45,574$8.14$370,972.363,853,555  
2/27/2019Fondation RennesMajor ShareholderBuy5,273$8.13$42,869.493,853,555  
2/6/2019Fondation RennesMajor ShareholderBuy65,000$9.19$597,350.003,590,182  
12/26/2018W Thorpe MckenzieDirectorBuy3,600$5.00$18,000.003,398,600  
12/24/2018W Thorpe MckenzieDirectorBuy24,838$5.88$146,047.443,398,600  
11/12/2018W Thorpe MckenzieDirectorBuy2,900$3.74$10,846.00  
10/4/2018W Thorpe MckenzieDirectorSell385,000$3.00$1,155,000.003,398,600  
9/26/2018W Thorpe MckenzieDirectorSell17,634$3.05$53,783.703,783,600  
9/13/2018W Thorpe MckenzieDirectorSell49,584$3.07$152,222.883,809,143  
9/10/2018W Thorpe MckenzieDirectorSell29,603$3.31$97,985.933,874,187  
9/7/2018W Thorpe MckenzieDirectorSell6,234$3.65$22,754.103,874,187  
8/10/2018W Thorpe MckenzieDirectorSell9,809$3.99$39,137.913,898,600  
8/8/2018W Thorpe MckenzieDirectorSell15,792$3.97$62,694.243,898,600  
8/6/2018W Thorpe MckenzieDirectorSell3,340$3.99$13,326.603,898,600  
8/3/2018W Thorpe MckenzieDirectorSell62,524$3.98$248,845.52  
7/31/2018W Thorpe MckenzieDirectorSell11,875$4.45$52,843.753,898,600  
3/23/2018Queena HanVPSell80,000$4.73$378,400.009,599  
3/21/2018Queena HanVPSell9,599$4.48$43,003.529,599  
11/15/2016Queena HanVPSell19,573$15.00$293,595.0019,573  
9/8/2016Queena HanVPSell427$15.00$6,405.00427  
5/26/2016W Thorpe MckenzieDirectorBuy20,000$13.96$279,200.003,898,600  
5/20/2016W Thorpe MckenzieDirectorBuy1,500$13.75$20,625.003,898,600  
12/22/2015Queena HanVPSell30,000$10.39$311,700.00  
11/16/2015Michael StecherDirectorSell1,800$14.00$25,200.00  
(Data available from 1/1/2013 forward)
This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.